Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply

Clarity Pharmaceuticals

24/03/2026 23:38

** Shares of Australia's Clarity Pharmaceuticals CU6.AX rise as much as 8.5% to A$3.33

** Stock hits biggest intraday pct gain since March 17

** The radiopharma firm signs an agreement with Cancer Research company, Theragenics, for copper-64

** Copper‑64 is used by biopharma companies to detect cancer-causing agents and for early treatment

** Despite moves, stock down 3.6% YTD

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))